Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omobolaji O Akala

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Genetics & Development|August 22, 2006
Hematopoietic stem cell self-renewalOmobolaji O Akala, Michael F Clarke
CPT: Pharmacometrics & Systems Pharmacology|June 12, 2024
A bootstrapping method to optimize go/no-go decisions from single-arm, signal-finding studies in oncologyRaunak Dutta, Aparna Mohan, Jacqueline Buros-Novik, et al.
Nature|April 18, 2008
Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitorsOmobolaji O Akala, In-Kyung Park, Dalong Qian, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18Graham L Cohen, Corlia Coetzee, Cathryn A Walton, et al.
Journal of Hematology & Oncology|June 6, 2025
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapiesQuchang Ouyang, Jordi Rodon, Yan Liang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Genetics & Development|August 22, 2006
Hematopoietic stem cell self-renewalOmobolaji O Akala, Michael F Clarke
CPT: Pharmacometrics & Systems Pharmacology|June 12, 2024
A bootstrapping method to optimize go/no-go decisions from single-arm, signal-finding studies in oncologyRaunak Dutta, Aparna Mohan, Jacqueline Buros-Novik, et al.
Nature|April 18, 2008
Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitorsOmobolaji O Akala, In-Kyung Park, Dalong Qian, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18Graham L Cohen, Corlia Coetzee, Cathryn A Walton, et al.
Journal of Hematology & Oncology|June 6, 2025
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapiesQuchang Ouyang, Jordi Rodon, Yan Liang, et al.
Pageof 1